Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14763820 | 1.00 | TSHR (0.56) | TSHRKDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL16674306 | 0.89 | TDP1 (0.41) | TSHRKDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL18616451 | 0.88 | TSHR (0.52) | TSHRALDH1A1TDP1L3MBTL1NAAA | |
| SCHEMBL19750824 | 0.87 | TSHR (0.47) | TSHRTDP1L3MBTL1NAAACYP2C19 | |
| SCHEMBL28515540 | 0.86 | TSHR (0.45) | TSHRALDH1A1TDP1L3MBTL1NAAA | |
| SCHEMBL16055690 | 0.85 | L3MBTL1 (0.54) | TSHRTDP1L3MBTL1 | |
| SCHEMBL10652311 | 0.85 | L3MBTL1 (0.54) | TSHRTDP1L3MBTL1 | |
| SCHEMBL10653320 | 0.85 | L3MBTL1 (0.54) | TSHRTDP1L3MBTL1 | |
| SCHEMBL28540750 | 0.84 | PPARG (0.41) | TSHRKDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL10052098 | 0.84 | TSHR (0.44) | TSHRKDM4EALDH1A1HSD17B10CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12195446-B2 | Heteroaryl compounds and their use as therapeutic drugs | DONG-A SOCIO HOLDINGS CO., LTD. (KR) | 2025-01-14 | — | — | US | claimed |
| US-20230002353-A1 | HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS | DONG A SOCIO HOLDINGS CO LTD (KR) | 2023-01-05 | — | — | US | claimed |
| US-10233337-B2 | Charge-transporting varnish | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-03-19 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-2822050-B1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL IND LTD (JP) | 2017-06-14 | — | — | EP | claimed |
| CN-104145348-B | Charge-transporting varnish | 日产化学工业株式会社 | 2017-03-08 | — | — | CN | claimed |
| US-20150053892-A1 | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-02-26 | — | — | US | claimed |
| CN-104145348-A | CHARGE-TRANSPORTING VARNISH | NISSAN CHEMICAL IND LTD | 2014-11-12 | — | — | CN | claimed |
| EP-0912505-A4 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2001-10-24 | — | — | EP | claimed |
| EP-0912505-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-05-06 | — | — | EP | claimed |
| WO-1997049680-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-12-31 | — | — | WO | claimed |
| US-5554588-A | IN WHICH AT LEAST HALF COMPRISES ETHERS, AROMATIC METHYL KETONES, ALCOHOLS, ESTERS AND SALICYLATES; DEODORANTS AND ACCEPTABLE FRAGRANCE | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1996-09-10 | — | — | US | claimed |
| US-6413925-B1 | — | — | None | — | — | US | disclosed |
| EP-4136067-B1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LTD (IN) | 2026-04-15 | — | — | EP | disclosed |
| US-12545852-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-02-10 | — | — | US | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-4002583-A | Substrate coating composition | OWENS-ILLINOIS, INC. (US) | 1977-01-11 | — | — | US | disclosed |
| US-3984350-A | Catalyst component comprising brown titanium trichloride | STANDARD OIL COMPANY (INDIANA) (US) | 1976-10-05 | — | — | US | disclosed |
| US-3933868-A | Process for the preparation of 1,5- and 1,8-diamino-anthraquinone | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-20 | — | — | US | disclosed |
| US-3933867-A | Process for the preparation of 1-aminoanthraquinone | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12195446-B2 | Heteroaryl compounds and their use as therapeutic drugs | MERTK, ERBB2, SRC | TSHR 1878/4885KDM4E 1727/4885ALDH1A1 3115/4885 |
| US-12545852-B2 | Odorants and compositions comprising odorants | ENY2, CDY1; CDY1B, CHRM5 | TSHR 2944/4885KDM4E 1249/4885ALDH1A1 453/4885 |
| US-20230002353-A1 | HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS | MERTK, ERBB2, SRC | TSHR 1878/4885KDM4E 1727/4885ALDH1A1 3115/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | TSHR 830/4885KDM4E 4214/4885ALDH1A1 3874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.